30.40USD-3.23%Mkt Cap: 2.37B USDP/E: —Last update: 2026-06-01
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap2.37B USD
Enterprise Value2.02B USD
Revenue (TTM)865.00K USD
Gross Profit-264.60M USD
Net Income (TTM)-258.76M USD
Revenue/Share0.0130 USD
Last Price30.40 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees198
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.91
PEG—
EV/EBITDA-6.60
EV/Revenue2332.32
P/S2852.03
P/B4.59
EPS (TTM)-4.27
EPS (Forward)-4.55
52W Range
18.8068% of range35.79
52W High35.79 USD
52W Low18.80 USD
Profitability
Gross Margin0.00%
Oper. Margin-562900.00%
EBITDA Margin0.00%
Profit Margin-16748.03%
ROE-49.08%
ROA-44.38%
Growth
Revenue Growth-97.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-210.94M USD
CapEx (TTM)2.71M USD
FCF Margin-14597.85%
FCF Yield-5.33%
Net Debt-449.55M USD
Net Debt/EBITDA1.47
Balance Sheet
Debt/Equity0.00
Current Ratio8.92
Quick Ratio8.78
Book Value/Sh6.853 USD
Cash/Share5.752 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateFeb 11, 2019
Splits
Last Split1:15
Split DateFeb 11, 2019
Analyst Consensus
Rating—
Target (Mean)58.43 USD
Target Range38.00 USD – 90.00 USD
# Analysts14
Ownership
Shares Out.78.49M
Float72.46M
Insiders0.27%
Institutions94.58%
Short Interest
Short Ratio9.1d
Short % Float10.78%
Short % Out.9.08%
Shares Short7.13M
Short (prev mo.)8.31M
Technical
SMA 5032.17 (-5.5%)
SMA 20027.45 (+10.8%)
Beta0.98
S&P 52W Chg27.94%
Avg Vol (30d)664.45K
Avg Vol (10d)683.37K
Technical Indicators
RSI (14)47.3
MACD-0.3441
MACD Signal-0.3023
MACD Hist.-0.0418
BB Upper34.50 USD
BB Middle31.98 USD
BB Lower29.45 USD
BB Width15.79%
ATR (14)1.313 USD
Vol Ratio (20d)0.20x